ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 14,250,000 shares; 2025Q1: 14,250,000 shares; 2025Q2: 14,250,000 shares; 2025Q3: 14,250,000 shares; 2025Q4: 14,250,000 shares; 2026Q1: 14,250,000 shares; 2026Q2: 11,975,000 shares; 2026Q3: 10,955,000 shares 10,955,000 $57.6M 30.92% -1,020,000 Timeline AVIR ATEA PHARMACEUTICALS INC More: the full row for ATEA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 7,608,312 shares; 2025Q1: 7,609,812 shares; 2025Q2: 7,609,812 shares; 2025Q3: 7,473,963 shares; 2025Q4: 7,490,000 shares; 2026Q1: 7,058,657 shares; 2026Q2: 6,952,330 shares; 2026Q3: 6,753,658 shares 6,753,658 $35.2M 18.88% -198,672 Timeline ENGN ENGENE THERAPEUTICS INC More: the full row for ENGENE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,669,908 shares; 2026Q3: 6,669,908 shares 6,669,908 $13.3M 7.16% 0 Timeline PMVP PMV PHARMACEUTICALS INC More: the full row for PMV PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,466,684 shares; 2025Q1: 3,747,612 shares; 2025Q2: 5,000,000 shares; 2025Q3: 5,292,000 shares; 2025Q4: 5,292,000 shares; 2026Q1: 5,320,000 shares; 2026Q2: 5,330,000 shares; 2026Q3: 7,330,000 shares 7,330,000 $12.2M 6.57% +2,000,000 Timeline KHC KRAFT HEINZ CO More: the full row for KRAFT HEINZ CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 125,000 shares; 2026Q2: 465,000 shares; 2026Q3: 475,000 shares 475,000 $10.8M 5.79% +10,000 Timeline TLYS TILLYS INC More: the full row for TILLYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,150,000 shares; 2026Q2: 2,150,000 shares; 2026Q3: 2,150,000 shares 2,150,000 $9.95M 5.34% 0 Timeline KMX CARMAX INC More: the full row for CARMAX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 155,000 shares; 2026Q1: 155,000 shares; 2026Q2: 172,500 shares; 2026Q3: 172,500 shares 172,500 $9.51M 5.1% 0 Timeline OM OUTSET MED INC More: the full row for OUTSET MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 543,180 shares; 2026Q1: 1,902,201 shares; 2026Q2: 2,519,701 shares; 2026Q3: 2,519,701 shares 2,519,701 $7.56M 4.06% 0 Timeline TGT TARGET CORP More: the full row for TARGET CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 37,500 shares; 2026Q1: 37,500 shares; 2026Q2: 37,500 shares; 2026Q3: 37,500 shares 37,500 $5.88M 3.15% 0 Timeline SEER SEER INC More: the full row for SEER INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,186,587 shares 2,186,587 $4.88M 2.62% new Timeline TIL INSTIL BIO INC More: the full row for INSTIL BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 400,000 shares; 2025Q1: 416,720 shares; 2025Q2: 534,899 shares; 2025Q3: 645,600 shares; 2025Q4: 645,600 shares; 2026Q1: 645,600 shares; 2026Q2: 645,600 shares; 2026Q3: 645,600 shares 645,600 $4.67M 2.51% 0 Timeline CNTB CONNECT BIOPHARMA HLDGS LTD More: the full row for CONNECT BIOPHARMA HLDGS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,267,500 shares; 2025Q4: 408,887 shares; 2026Q1: 408,887 shares; 2026Q2: 573,287 shares; 2026Q3: 3,864,400 shares 3,864,400 $4.25M 2.28% +3,291,113 Timeline ORMP ORAMED PHARMACEUTICALS INC More: the full row for ORAMED PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,643,907 shares; 2025Q1: 3,020,748 shares; 2025Q2: 3,083,253 shares; 2025Q3: 3,167,231 shares; 2025Q4: 3,167,231 shares; 2026Q1: 3,167,231 shares; 2026Q2: 866,269 shares; 2026Q3: 884,392 shares 884,392 $4.13M 2.22% +18,123 Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 154,961 shares; 2026Q2: 154,961 shares; 2026Q3: 151,126 shares 151,126 $2.61M 1.4% -3,835 Timeline PLRX PLIANT THERAPEUTICS INC More: the full row for PLIANT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,546,137 shares; 2026Q1: 1,546,137 shares; 2026Q2: 1,546,137 shares; 2026Q3: 1,546,137 shares 1,546,137 $1.67M 0.9% 0 Timeline LENZ LENZ THERAPEUTICS INC More: the full row for LENZ THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 9,271 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 283,114 shares 283,114 $1.09M 0.58% new Timeline IMA IMAGENEBIO INC More: the full row for IMAGENEBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 182,509 shares; 2025Q4: 177,026 shares; 2026Q1: 200,730 shares; 2026Q2: 200,730 shares; 2026Q3: 200,730 shares 200,730 $919K 0.49% 0 Timeline KPTI KARYOPHARM THERAPEUTICS INC More: the full row for KARYOPHARM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 71,839 shares 71,839 $87.6K 0.05% new Timeline